Print

Purpose

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.

Condition

Eligibility

Eligible Ages
Between 50 Years and 100 Years
Eligible Genders
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient is a female, ≥ 50 years of age - The tumor size is ≤ 3 cm (on pre-study radiologic OR clinical exam) - The tumor is unicentric and unilateral - The tumor is not involving the skin - Pathology confirms ductal in situ (DCIS) OR infiltrating ductal carcinoma (IDC), grade I-III - If tumor is IDC, pathology must be hormone receptor positive (ER+ and/or PR+) - Patient signs current written informed consent and HIPAA forms

Exclusion Criteria

  • Patient is under 50 years of age - Patient is male - Tumor > 3 cm in diameter - Bilateral malignancy - Clinically positive lymph nodes - Tumor involving the skin - Pathology confirms invasive lobular carcinoma - Breast implants - Less than 2 years disease-free survival from previous breast cancer - Neoadjuvant chemotherapy or chemotherapy for another breast cancer within two years

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
Surgery followed by RFA
  • Device: Radiofrequency Ablation
    Breast conservation surgery followed by Radiofrequency Ablation of the cavity
    Other names:
    • AngioDynamics, Inc.

Recruiting Locations

More Details

NCT ID
NCT01153035
Status
Active, not recruiting
Sponsor
University of Arkansas

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.